Only Wegovy now has the supporting evidence on relevant outcomes, which Novo Nordisk is set to convert into an expanded label and use with payers to broaden coverage
If you find yourself unusually worn out, lacking energy, or feeling weak, its a good idea to let your healthcare provider know
However, its important to remember that weight loss is a gradual process and can be influenced by various factors, including diet, exercise, metabolism, and individual response to the medication
1 summarizes the several characteristics between single agonism using GLP-1 and dual agonism of GLP-1/GIP (i.e., tirzepatide) treatment
What Medical Sources Say About Berberine And GLP-1 Medications Medical literature highlights caution rather than endorsement
Zhao, F